Enzymatics manufactures DNA modifying enzymes, which are used in experiments for finding new drugs. The growing market of $300 million for these consumable products has limited competition. The goal is to develop a company which will supply high quality DNA modifying enzymes in large quantities at half the current price to genomics companies. The company was founded by two seasoned scientists that have been leaders in the largest molecular biology enzyme company.
Enzymatics is focused on large scale, high quality enzyme production. The Company has applied 30 years of aggregate experience in the development, optimization, and scale-up of recombinant bio-production to make its customers' reagents business more reliable and more profitable. Drawing elements from several modern manufacturing strategies, Enzymatics has refined the biological reagents production process - from cloning the target gene to quality control testing of the final formulation.
The result of this process development is a measurable increase in the quality of our reagent products while maintaining the flexibility to compete on price.
www.enzymatics.com
|
